No Data
What's Going On With Tonix Pharmaceuticals Shares Friday?
Tonix Pharmaceutical Shares Are Trading Higher After the Company Provided Preliminary Q4 Financial Results.
Tonix Pharmaceuticals Reports FY24 Preliminary Financials: $98.8M In Cash And Cash Equivalents As Of December 31, 2024, Revenue Hits ~$10.1M Vs $7.8M YoY
Express News | Tonix Pharmaceuticals Holding Corp - Is Now Debt-Free After Repaying Mortgage
Express News | Tonix Pharmaceuticals Holding Corp - FDA Pdufa Goal Date for Tnx-102 Sl Is August 15, 2025
Press Release: Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
